Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to improve awareness of haemochromatosis and related clinical recommendations.

Genomic testing for haemochromatosis is available through the NHS Genomic Medicine Service (GMS) for patients in England who show unexplained iron overload suggestive of hereditary haemochromatosis. Seven NHS GMS alliances play an important role in supporting the strategic systematic embedding of genomic medicine in end-to-end clinical pathways and clinical specialities, including raising awareness among clinicians and the public of the genomic testing available through the National Health Service. The alliances drive this embedding across all providers within their geography from primary and community care to secondary and tertiary care. The Genomics Education Programme also provides clinicians digital resources on diagnostics and genomic testing in both primary and secondary care.